{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T22:01:49Z","timestamp":1780351309679,"version":"3.54.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,21]],"date-time":"2020-11-21T00:00:00Z","timestamp":1605916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,21]],"date-time":"2020-11-21T00:00:00Z","timestamp":1605916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"SENDIMAD","award":["BECA SENDIMAD de Ayuda a la Investigaci\u00f3n en Endocrinolog\u00eda, Nutrici\u00f3n y Diabetes 2019"],"award-info":[{"award-number":["BECA SENDIMAD de Ayuda a la Investigaci\u00f3n en Endocrinolog\u00eda, Nutrici\u00f3n y Diabetes 2019"]}]},{"name":"SENDIMAD","award":["BECA SENDIMAD de Ayuda a la Investigaci\u00f3n en Endocrinolog\u00eda, Nutrici\u00f3n y Diabetes 2019"],"award-info":[{"award-number":["BECA SENDIMAD de Ayuda a la Investigaci\u00f3n en Endocrinolog\u00eda, Nutrici\u00f3n y Diabetes 2019"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s12020-020-02544-6","type":"journal-article","created":{"date-parts":[[2020,11,21]],"date-time":"2020-11-21T11:02:31Z","timestamp":1605956551000},"page":"40-48","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Urine steroid profile as a new promising tool for the evaluation of adrenal tumors. Literature review"],"prefix":"10.1007","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0519-0072","authenticated-orcid":false,"given":"Marta","family":"Araujo-Castro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Valderr\u00e1bano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9ctor F.","family":"Escobar-Morreale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia A.","family":"Hanzu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3271-1371","authenticated-orcid":false,"given":"Gregori","family":"Casals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,21]]},"reference":[{"issue":"1","key":"2544_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12020-019-01888-y","volume":"64","author":"M Araujo-Castro","year":"2019","unstructured":"M. Araujo-Castro, M.A. Sampedro N\u00fa\u00f1ez, M. Marazuela, Autonomous cortisol secretion in adrenal incidentalomas. Endocrine 64(1), 1\u201313 (2019). https:\/\/doi.org\/10.1007\/s12020-019-01888-y","journal-title":"Endocrine"},{"issue":"6","key":"2544_CR2","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.endinu.2020.03.002","volume":"67","author":"M Araujo-Castro","year":"2020","unstructured":"M. Araujo-Castro, M. Iturregui Guevara, M. Calatayud Guti\u00e9rrez, P. Parra Ram\u00edrez, P. Gracia Gimeno, F.A. Hanzu et al. Practical guide on the initial evaluation, follow-up, and treatment of adrenal incidentalomas Adrenal Diseases Group of the Spanish Society of Endocrinology and Nutrition. Endocrinol. Diabetes Nutr. 67(6), 408\u2013419 (2020). https:\/\/doi.org\/10.1016\/j.endinu.2020.03.002","journal-title":"Endocrinol. Diabetes Nutr."},{"issue":"2","key":"2544_CR3","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-16-0467","volume":"175","author":"M Fassnacht","year":"2016","unstructured":"M. Fassnacht, W. Arlt, I. Bancos, H. Dralle, J. Newell-Price, A. Sahdev et al. Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur. J. Endocrinol. 175(2), G1\u2013G34 (2016). https:\/\/doi.org\/10.1530\/EJE-16-0467","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"2544_CR4","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3803\/EnM.2017.32.2.200","volume":"32","author":"JM Lee","year":"2017","unstructured":"J.M. Lee, M.K. Kim, S.H. Ko, J.M. Koh, B.Y. Kim, S.W. Kim et al. Clinical guidelines for the management of adrenal incidentaloma. Endocrinol Metab (Seoul). 32(2), 200\u2013218 (2017). https:\/\/doi.org\/10.3803\/EnM.2017.32.2.200","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"5","key":"2544_CR5","doi-asserted-by":"publisher","first-page":"424","DOI":"10.7326\/0003-4819-138-5-200303040-00013","volume":"138","author":"MM Grumbach","year":"2003","unstructured":"M.M. Grumbach, B.M.K. Biller, G.D. Braunstein, K.K. Campbell, J. Aidan Carney, P.A. Godley et al. Management of the clinically inapparent adrenal mass (\u201cincidentaloma\u201d). Ann. Intern. Med. 138(5), 424\u2013429 (2003). https:\/\/doi.org\/10.7326\/0003-4819-138-5-200303040-00013","journal-title":"Ann. Intern. Med"},{"issue":"2","key":"2544_CR6","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1210\/jc.2004-1627","volume":"90","author":"AH Hamrahian","year":"2005","unstructured":"A.H. Hamrahian, A.G. Ioachimescu, E.M. Remer, G. Motta-Ramirez, H. Bogabathina, H.S. Levin et al. Clinical utility of noncontrast computed tomography attenuation value (hounsfield units) to differentiate adrenal adenomas\/hyperplasias from nonadenomas: Cleveland clinic experience. J. Clin. Endocrinol. Metab. 90(2), 871\u2013877 (2005). https:\/\/doi.org\/10.1210\/jc.2004-1627","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"2544_CR7","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1530\/EJE-09-0234","volume":"161","author":"TJ Cawood","year":"2009","unstructured":"T.J. Cawood, P.J. Hunt, D. O\u2019Shea, D. Cole, S. Soule, Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink?. Eur. J. Endocrinol. 161(4), 513\u2013527 (2009). https:\/\/doi.org\/10.1530\/EJE-09-0234","journal-title":"Eur. J. Endocrinol."},{"issue":"5","key":"2544_CR8","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"J.W. Funder, R.M. Carey, F. Mantero, M.H. Murad, M. Reincke, H. Shibata et al. The management of primary aldosteronism: Case detection, diagnosis, and treatment: An endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 101(5), 1889\u20131916 (2016). https:\/\/doi.org\/10.1210\/jc.2015-4061","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"2544_CR9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11154-011-9163-7","volume":"12","author":"E Fischer","year":"2011","unstructured":"E. Fischer, F. Beuschlein, M. Bidlingmaier, M. Reincke, Commentary on the Endocrine Society Practice Guidelines: Consequences of adjustment of antihypertensive medication in screening of primary aldosteronism. Rev. Endocr. Metab. Disord. 12(1), 43\u201348 (2011). https:\/\/doi.org\/10.1007\/s11154-011-9163-7","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"5","key":"2544_CR10","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1210\/jc.2010-2722","volume":"96","author":"I Chiodini","year":"2011","unstructured":"I. Chiodini, Diagnosis and treatment of subclinical hypercortisolism. J. Clin. Endocrinol. Metab. 96(5), 1223\u20131236 (2011). https:\/\/doi.org\/10.1210\/jc.2010-2722","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"2544_CR11","first-page":"917","volume":"67","author":"AA Gheorghisan-galateanu","year":"2017","unstructured":"A.A. Gheorghisan-galateanu, M. Carsote, A. Valea, Incidentaloma: from general practice to specific endocrine frame. J. Pak. Med. Assoc. 67(6), 917\u2013922 (2017)","journal-title":"J. Pak. Med. Assoc."},{"issue":"9","key":"2544_CR12","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1210\/jc.2008-0104","volume":"93","author":"JW Funder","year":"2008","unstructured":"J.W. Funder, R.M. Carey, C. Fardella, C.E. Gomez-Sanchez, F. Mantero, M. Stowasser et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 93(9), 3266\u20133281 (2008). https:\/\/doi.org\/10.1210\/jc.2008-0104","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"2544_CR13","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.metabol.2010.01.007","volume":"59","author":"M Peppa","year":"2010","unstructured":"M. Peppa, E. Boutati, C. Koliaki, N. Papaefstathiou, E. Garoflos, T. Economopoulos et al. Insulin resistance and metabolic syndrome in patients with nonfunctioning adrenal incidentalomas: a cause-effect relationship? Metabolism 59(10), 1435\u20131441 (2010). https:\/\/doi.org\/10.1016\/j.metabol.2010.01.007","journal-title":"Metabolism"},{"issue":"4","key":"2544_CR14","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s12672-015-0224-3","volume":"6","author":"TMA Kerkhofs","year":"2015","unstructured":"T.M.A. Kerkhofs, M.N. Kerstens, I.P. Kema, T.P. Willems, H.R. Haak, Diagnostic value of urinary steroid profiling in the evaluation of adrenal tumors. Horm. Cancer 6(4), 168\u2013175 (2015). https:\/\/doi.org\/10.1007\/s12672-015-0224-3","journal-title":"Horm. Cancer"},{"issue":"12","key":"2544_CR15","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.1210\/jc.2011-1565","volume":"96","author":"W Arlt","year":"2011","unstructured":"W. Arlt, M. Biehl, A.E. Taylor, S. Hahner, R. Lib\u00e9, B.A. Hughes et al. Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors. J. Clin. Endocrinol. Metab. 96(12), 3775\u20133784 (2011). https:\/\/doi.org\/10.1210\/jc.2011-1565","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5-6","key":"2544_CR16","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s12672-016-0267-0","volume":"7","author":"LI Velikanova","year":"2016","unstructured":"L.I. Velikanova, Z.R. Shafigullina, A.A. Lisitsin, N.V. Vorokhobina, K. Grigoryan, E.A. Kukhianidze et al. Different types of urinary steroid profiling obtained by high-performance liquid chromatography and gas chromatography-mass spectrometry in patients with adrenocortical carcinoma. Horm. Cancer 7(5-6), 327\u2013335 (2016). https:\/\/doi.org\/10.1007\/s12672-016-0267-0","journal-title":"Horm. Cancer"},{"key":"2544_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.steroids.2018.04.006","volume":"135","author":"ZR Shafigullina","year":"2018","unstructured":"Z.R. Shafigullina, L.I. Velikanova, N.V. Vorokhobina, S.B. Shustov, A.A. Lisitsin, E.V. Malevanaia et al. Urinary steroid profiling by gas chromatography mass spectrometry: Early features of malignancy in patients with adrenal incidentalomas. Steroids 135, 31\u201335 (2018). https:\/\/doi.org\/10.1016\/j.steroids.2018.04.006","journal-title":"Steroids"},{"issue":"3","key":"2544_CR18","doi-asserted-by":"publisher","first-page":"e307","DOI":"10.1210\/clinem\/dgz141","volume":"105","author":"V Chortis","year":"2020","unstructured":"V. Chortis, I. Bancos, T. Nijman, L.C. Gilligan, A.E. Taylor, C.L. Ronchi et al. Urine steroid metabolomics as a novel tool for detection of recurrent adrenocortical carcinoma. J. Clin. Endocrinol. Metab. 105(3), e307\u2013e318 (2020). https:\/\/doi.org\/10.1210\/clinem\/dgz141","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"2544_CR19","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s002689900442","volume":"22","author":"A Khorram-Manesh","year":"1998","unstructured":"A. Khorram-Manesh, H. Ahlman, S. Jansson, B. W\u00e4ngberg, O. Nilsson, C.E. Jakobsson et al. Adrenocortical carcimona: surgery and mitotane for treatment and steroid profiles for follow-up. World J. Surg. 22(6), 605\u2013611 (1998). https:\/\/doi.org\/10.1007\/s002689900442.","journal-title":"World J. Surg."},{"issue":"6","key":"2544_CR20","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.clinbiochem.2008.12.027","volume":"42","author":"A Kot\u0142owska","year":"2009","unstructured":"A. Kot\u0142owska, E. Mali\u0144ski, K. Sworczak, J. Kumirska, P. Stepnowski, The urinary steroid profile in patients diagnosed with adrenal incidentaloma. Clin. Biochem. 42(6), 448\u2013454 (2009). https:\/\/doi.org\/10.1016\/j.clinbiochem.2008.12.027","journal-title":"Clin. Biochem."},{"issue":"5\u20136","key":"2544_CR21","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.jchromb.2010.12.021","volume":"879","author":"A Kot\u0142owska","year":"2011","unstructured":"A. Kot\u0142owska, K. Sworczak, P. Stepnowski, Urine metabolomics analysis for adrenal incidentaloma activity detection and biomarker discovery. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 879(5\u20136), 359\u2013363 (2011)","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"10","key":"2544_CR22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11906-019-0985-0","volume":"21","author":"F Holler","year":"2019","unstructured":"F. Holler, D.A. Heinrich, C. Adolf, B. Lechner, M. Bidlingmaier, G. Eisenhofer et al. Steroid profiling and immunohistochemistry for subtyping and outcome prediction in primary aldosteronism\u2014a review. Curr. Hypertens. Rep. 21(10), 77 (2019). https:\/\/doi.org\/10.1007\/s11906-019-0985-0","journal-title":"Curr. Hypertens. Rep."},{"issue":"8","key":"2544_CR23","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.93136","volume":"2","author":"W Arlt","year":"2017","unstructured":"W. Arlt, K. Lang, A.J. Sitch, A.S. Dietz, Y. Rhayem, I. Bancos et al. Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism. JCI Insight 2(8), e93136 (2017). https:\/\/doi.org\/10.1172\/jci.insight.93136","journal-title":"JCI Insight"},{"issue":"3","key":"2544_CR24","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1161\/HYPERTENSIONAHA.118.11465","volume":"72","author":"LS Meyer","year":"2018","unstructured":"L.S. Meyer, X. Wang, E. Su\u0161nik, J. Burrello, A. Burrello, I. Castellano et al. Immunohistopathology and steroid profiles associated with biochemical outcomes after adrenalectomy for unilateral primary aldosteronism. Hypertension 72(3), 650\u2013657 (2018). https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.118.11465","journal-title":"Hypertension"},{"issue":"3","key":"2544_CR25","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1210\/jc.2011-2384","volume":"97","author":"P Mulatero","year":"2012","unstructured":"P. Mulatero, S.M. Di Cella, S. Monticone, D. Schiavone, M. Manzo, G. Mengozzi et al. 18-hydroxycorticosterone, 18-hydroxycortisol, and 18-oxocortisol in the diagnosis of primary aldosteronism and its subtypes. J. Clin. Endocrinol. Metab. 97(3), 881\u2013889 (2012). https:\/\/doi.org\/10.1210\/jc.2011-2384","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"2544_CR26","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3390\/biomedicines8090314","volume":"8","author":"C Rossi","year":"2020","unstructured":"C. Rossi, I. Cicalini, S. Verrocchio, G. Di Dalmazi, L. Federici, I. Bucci, The potential of steroid profiling by mass spectrometry in the management of adrenocortical carcinoma. Biomedicines 8(9), 314 (2020). https:\/\/doi.org\/10.3390\/biomedicines8090314","journal-title":"Biomedicines"},{"issue":"4","key":"2544_CR27","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3343\/alm.2020.40.4.285","volume":"40","author":"G Casals","year":"2020","unstructured":"G. Casals, F.A. Hanzu, Cortisol measurements in Cushing\u2019s syndrome: immunoassay or mass spectrometry? Ann. Lab. Med. 40(4), 285\u2013296 (2020). https:\/\/doi.org\/10.3343\/alm.2020.40.4.285","journal-title":"Ann. Lab. Med."},{"issue":"5","key":"2544_CR28","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s11102-016-0730-5","volume":"19","author":"G Aranda","year":"2016","unstructured":"G. Aranda, M. Careaga, F.A. Hanzu, I. Patrascioiu, P. R\u00edos, M. Mora et al. Accuracy of immunoassay and mass spectrometry urinary free cortisol in the diagnosis of Cushing\u2019s syndrome. Pituitary 19(5), 496\u2013502 (2016). https:\/\/doi.org\/10.1007\/s11102-016-0730-5","journal-title":"Pituitary"},{"key":"2544_CR29","unstructured":"P.C. White, Trastornos de la gl\u00e1ndula suprarrenal suprarrenal. In: Nelson. Tratado de pediatr\u00eda, pp. 2403\u20132420. (Elsevier, Espa\u00f1a, S.L.U. 2020)"},{"issue":"2","key":"2544_CR30","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ecl.2005.01.002","volume":"34","author":"W Arlt","year":"2005","unstructured":"W. Arlt, P.M. Stewart, Adrenal corticosteroid biosynthesis, metabolism, and action. Endocrinol. Metab. Clin. N. Am. 34(2), 293\u2013313 (2005). https:\/\/doi.org\/10.1016\/j.ecl.2005.01.002","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"issue":"8","key":"2544_CR31","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1210\/js.2018-00135","volume":"2","author":"C Shackleton","year":"2018","unstructured":"C. Shackleton, O.J. Pozo, J. Marcos, GC\/MS in recent years has defined the normal and clinically disordered steroidome: will it soon be surpassed by LC\/tandem MS in this role? J. Endocr. Soc. 2(8), 974\u2013996 (2018)","journal-title":"J. Endocr. Soc."},{"issue":"3\u20135","key":"2544_CR32","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.jsbmb.2010.04.010","volume":"121","author":"N Krone","year":"2010","unstructured":"N. Krone, B.A. Hughes, G.G. Lavery, P.M. Stewart, W. Arlt, C.H.L. Shackleton, Gas chromatography\/mass spectrometry (GC\/MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC\/MS\/MS). J. Steroid Biochem. Mol. Biol. 121(3\u20135), 496\u2013504 (2010)","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"2544_CR33","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/s0378-4347(00)80683-0","volume":"379","author":"CHL Shackleton","year":"1986","unstructured":"C.H.L. Shackleton, Profiling steroid hormones and urinary steroids. J. Chromatogr. 379, 91\u2013156 (1986). https:\/\/doi.org\/10.1016\/s0378-4347(00)80683-0","journal-title":"J. Chromatogr."},{"issue":"1-3","key":"2544_CR34","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0960-0760(93)90132-g","volume":"45","author":"CHL Shackleton","year":"1993","unstructured":"C.H.L. Shackleton, Mass spectrometry in the diagnosis of steroid-related disorders and in hypertension research. J. Steroid Biochem. Mol. Biol. 45(1-3), 127\u2013140 (1993). https:\/\/doi.org\/10.1016\/0960-0760(93)90132-g","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"6","key":"2544_CR35","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1210\/er.2018-00262","volume":"40","author":"K-H Storbeck","year":"2019","unstructured":"K.-H. Storbeck, L. Schiffer, E.S. Baranowski, V. Chortis, A. Prete, L. Barnard et al. Steroid metabolome analysis in disorders of adrenal steroid biosynthesis and metabolism. Endocr. Rev. 40(6), 1605\u20131625 (2019). https:\/\/doi.org\/10.1210\/er.2018-00262","journal-title":"Endocr. Rev."},{"key":"2544_CR36","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jsbmb.2018.02.013","volume":"181","author":"JW Honour","year":"2018","unstructured":"J.W. Honour, E. Conway, R. Hodkinson, F. Lam, The evolution of methods for urinary steroid metabolomics in clinical investigations particularly in childhood. J. Steroid Biochem. Mol. Biol. 181, 28\u201351 (2018). https:\/\/doi.org\/10.1016\/j.jsbmb.2018.02.013","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"10","key":"2544_CR37","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1210\/jc.2013-3375","volume":"98","author":"DJ Handelsman","year":"2013","unstructured":"D.J. Handelsman, L. Wartofsky, Requirement for mass spectrometry sex steroid assays in the journal of clinical endocrinology and metabolism. J. Clin. Endocrinol. Metab. 98(10), 3971\u20133973 (2013). https:\/\/doi.org\/10.1210\/jc.2013-3375","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"2544_CR38","doi-asserted-by":"publisher","first-page":"533","DOI":"10.7326\/M16-0547","volume":"165","author":"D Lopez","year":"2016","unstructured":"D. Lopez, M.A. Luque-Fernandez, A. Steele, G.K. Adler, A. Turchin, A. Vaidya, \u201cNonfunctional\u201d adrenal Tumors and the risk for incident diabetes and cardiovascular outcomes: a cohort study. Ann. Intern. Med. 165(8), 533\u2013542 (2016). https:\/\/doi.org\/10.7326\/M16-0547","journal-title":"Ann. Intern. Med."},{"issue":"5","key":"2544_CR39","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1210\/jc.2008-0125","volume":"93","author":"LK Nieman","year":"2008","unstructured":"L.K. Nieman, B.M.K.K. Biller, J.W. Findling, J. Newell-Price, M.O. Savage, P.M. Stewart et al. The diagnosis of Cushing\u2019s Syndrome: an Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 93(5), 1526\u20131540 (2008). https:\/\/doi.org\/10.1210\/jc.2008-0125","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"2544_CR40","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.clinbiochem.2009.04.011","volume":"42","author":"R Gatti","year":"2009","unstructured":"R. Gatti, G. Antonelli, M. Prearo, P. Spinella, E. Cappellin, E.F. De Palo, Cortisol assays and diagnostic laboratory procedures in human biological fluids. Clin. Biochem. 42(12), 1205\u20131217 (2009). https:\/\/doi.org\/10.1016\/j.clinbiochem.2009.04.011","journal-title":"Clin. Biochem."},{"issue":"2","key":"2544_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms18020294","volume":"18","author":"A Kot\u0142owska","year":"2017","unstructured":"A. Kot\u0142owska, T. Puzyn, K. Sworczak, P. Stepnowski, P. Szefer, Metabolomic biomarkers in urine of cushing\u2019s syndrome patients. Int. J. Mol. Sci. 18(2), 1\u201315. (2017)","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"2544_CR42","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/BF01736807","volume":"65","author":"J Homoki","year":"1987","unstructured":"J. Homoki, R. Holl, W.M. Teller, Urinary steroid profiles in Cushing\u2019s syndrome and tumors of the adrenal cortex. Klin. Wochenschr. 65(15), 719\u2013726 (1987). https:\/\/doi.org\/10.1007\/BF01736807","journal-title":"Klin. Wochenschr."},{"issue":"1","key":"2544_CR43","doi-asserted-by":"publisher","first-page":"194s","DOI":"10.1016\/s0753-3322(00)80043-8","volume":"54","author":"E Kikuchi","year":"2000","unstructured":"E. Kikuchi, H. Yanaihara, J. Nakashima, K. Homma, T. Ohigashi, H. Asakura et al. Urinary steroid profile in adrenocortical tumors. Biomed. Pharmacother. 54(1), 194s\u2013197s (2000). https:\/\/doi.org\/10.1016\/s0753-3322(00)80043-8","journal-title":"Biomed. Pharmacother."},{"issue":"12","key":"2544_CR44","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.1210\/jcem.80.12.8530609","volume":"80","author":"PM Stewart","year":"1995","unstructured":"P.M. Stewart, B.R. Walker, G. Holder, D. O\u2019Halloran, C.H.L. Shackleton, 11 beta-Hydroxysteroid dehydrogenase activity in Cushing\u2019s syndrome: explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome. J. Clin. Endocrinol. Metab. 80(12), 3617\u20133620 (1995). https:\/\/doi.org\/10.1210\/jcem.80.12.8530609","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"2544_CR45","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/cen.12717","volume":"84","author":"J Brossaud","year":"2016","unstructured":"J. Brossaud, D. Ducint, J.B. Corcuff, Urinary glucocorticoid metabolites: biomarkers to classify adrenal incidentalomas. Clin. Endocrinol. (Oxf.) 84(2), 236\u201343. (2016)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"12","key":"2544_CR46","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1373\/clinchem.2017.271106","volume":"63","author":"JM Hines","year":"2017","unstructured":"J.M. Hines, I. Bancos, C. Bancos, R.D. Singh, A.V. Avula, W.F. Young et al. High-resolution, accurate-mass (HRAM) mass spectrometry urine steroid profiling in the diagnosis of adrenal disorders. Clin. Chem. 63(12), 1824\u20131835 (2017). https:\/\/doi.org\/10.1373\/clinchem.2017.271106","journal-title":"Clin. Chem."},{"issue":"1","key":"2544_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/EJE-14-0061","volume":"171","author":"F Ceccato","year":"2014","unstructured":"F. Ceccato, G. Antonelli, M. Barbot, M. Zilio, L. Mazzai, R. Gatti et al. The diagnostic performance of urinary free cortisol is better than the cortisol: Cortisone ratio in detecting de novo Cushing\u2019s Syndrome: The use of a LC-MS\/MS method in routine clinical practice. Eur J Endocrinol 171(1), 1\u20137 (2014). https:\/\/doi.org\/10.1530\/EJE-14-0061","journal-title":"Eur J Endocrinol"},{"key":"2544_CR48","doi-asserted-by":"publisher","unstructured":"Araujo-castro M. Treatment of primary hyperaldosteronism. Med. Clin. (Barc). S0025-7753(20)30323-7,(2020). https:\/\/doi.org\/10.1016\/j.medcli.2020.04.029","DOI":"10.1016\/j.medcli.2020.04.029"},{"issue":"6","key":"2544_CR49","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1055\/a-1141-3526","volume":"52","author":"T Wannachalee","year":"2020","unstructured":"T. Wannachalee, A.F. Turcu, Developments in primary aldosteronism subtyping using steroid profiling. Horm. Metab. Res. 52(6), 373\u2013378 (2020). https:\/\/doi.org\/10.1055\/a-1141-3526","journal-title":"Horm. Metab. Res."},{"issue":"4","key":"2544_CR50","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1210\/jcem.76.4.8473399","volume":"76","author":"S Ulick","year":"1993","unstructured":"S. Ulick, J.D. Blumenfeld, S.A. Atlas, J.Z. Wang, E.D. Vaughan, The unique steroidogenesis of the aldosteronoma in the differential diagnosis of primary aldosteronism. J. Clin. Endocrinol. Metab. 76(4), 873\u2013878 (1993). https:\/\/doi.org\/10.1210\/jcem.76.4.8473399","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"2544_CR51","doi-asserted-by":"publisher","first-page":"101400","DOI":"10.1016\/j.beem.2020.101400","volume":"34","author":"M Wolley","year":"2020","unstructured":"M. Wolley, M. Thuzar, M. Stowasser, Controversies and advances in adrenal venous sampling in the diagnostic workup of primary aldosteronism. Best. Pract. Res. Clin. Endocrinol. Metab. 34(3), 101400 (2020). https:\/\/doi.org\/10.1016\/j.beem.2020.101400","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"issue":"9-10","key":"2544_CR52","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.3109\/10641968209061640","volume":"4","author":"S Ulick","year":"1982","unstructured":"S. Ulick, M.D. Chu, Hypersecretion of a new corticosteroid, 18-hydroxycortisol in two types of adrenocortical hypertension. Clin. Exp. Hypertens. A. 4(9-10), 1771\u20131777 (1982). https:\/\/doi.org\/10.3109\/10641968209061640","journal-title":"Clin. Exp. Hypertens. A."},{"issue":"4","key":"2544_CR53","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1440-1681.1986.tb00357.x","volume":"13","author":"RD Gordon","year":"1986","unstructured":"R.D. Gordon, S.M. Hamlet, T.J. Tunny, C.E. Gomez\u2010Sanchez, L.S. Jayasinghed\u030a, Distinguishing aldosterone-producing adenoma from other forms of hyperaldosteronism and lateralizing the tumour pre-operatively. Clin. Exp. Pharmacol. Physiol. 13(4), 325\u2013328 (1986). https:\/\/doi.org\/10.1111\/j.1440-1681.1986.tb00357.x","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"12","key":"2544_CR54","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1111\/jch.12916","volume":"18","author":"JL Benham","year":"2016","unstructured":"J.L. Benham, M. Eldoma, B. Khokhar, D.J. Roberts, D.M. Rabi, G.A. Kline, Proportion of patients with hypertension resolution following adrenalectomy for primary aldosteronism: a systematic review and meta-analysis. J. Clin. Hypertens. (Greenwich) 18(12), 1205\u20131212 (2016). https:\/\/doi.org\/10.1111\/jch.12916","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"issue":"6","key":"2544_CR55","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1530\/EJE-10-1147","volume":"164","author":"M Terzolo","year":"2011","unstructured":"M. Terzolo, A. Stigliano, I. Chiodini, P. Loli, L. Furlani, G. Arnaldi et al. AME position statement on adrenal incidentaloma. Eur. J. Endocrinol. 164(6), 851\u2013870 (2011). https:\/\/doi.org\/10.1530\/EJE-10-1147","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"2544_CR56","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1507\/endocrj1954.32.29","volume":"32","author":"S Minowada","year":"1985","unstructured":"S. Minowada, K. Kinoshita, M. Hara, K. Isurugi, T. Uchikawa, T. Niijima, Measurement of urinary steroid profile in patients with adrenal tumor as a screening method for carcinoma. Endocrinol. Jpn. 32(1), 29\u201337 (1985). https:\/\/doi.org\/10.1507\/endocrj1954.32.29","journal-title":"Endocrinol. Jpn."},{"issue":"5","key":"2544_CR57","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1530\/acta.0.1220656","volume":"122","author":"S Grondal","year":"1990","unstructured":"S. Grondal, B. Eriksson, L. Hagenas, S. Werner, T. Curstedt, Steroid profile in urine: a useful tool in the diagnosis and follow up of adrenocortical carcinoma. Acta Endocrinol. (Copenh) 122(5), 656\u2013663 (1990). https:\/\/doi.org\/10.1530\/acta.0.1220656","journal-title":"Acta Endocrinol. (Copenh)"},{"issue":"3","key":"2544_CR58","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/MED.0000000000000333","volume":"24","author":"I Bancos","year":"2017","unstructured":"I. Bancos, W. Arlt, Diagnosis of a malignant adrenal mass: the role of urinary steroid metabolite profiling. Curr. Opin. Endocrinol. Diabetes Obes. 24(3), 200\u2013207 (2017). https:\/\/doi.org\/10.1097\/MED.0000000000000333","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"6","key":"2544_CR59","first-page":"463","volume":"15","author":"SC Tiu","year":"2009","unstructured":"S.C. Tiu, A.O.K. Chan, N.F. Taylor, C.Y. Lee, P.Y. Loung, C.H. Choi et al. Use of urinary steroid profiling for diagnosing and monitoring adrenocortical tumours. Hong Kong Med. J. 15(6), 463\u2013470 (2009)","journal-title":"Hong Kong Med. J."},{"issue":"9","key":"2544_CR60","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/S2213-8587(20)30218-7","volume":"8","author":"I Bancos","year":"2020","unstructured":"I. Bancos, A.E. Taylor, V. Chortis, A.J. Sitch, C. Jenkinson, C.J. Davidge-Pitts et al. Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study. Lancet Diabetes Endocrinol. 8(9), 773\u2013781 (2020). https:\/\/doi.org\/10.1016\/S2213-8587(20)30218-7","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"4","key":"2544_CR61","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/0046-8177(93)90088-x","volume":"24","author":"H Sasano","year":"1993","unstructured":"H. Sasano, T. Suzuki, H. Nagura, T. Nishikawa, Steroidogenesis in human adrenocortical carcinoma: Biochemical activities, immunohistochemistry, and in situ hybridization of steroidogenic enzymes and histopathologic study in nine cases. Hum. Pathol. 24(4), 397\u2013404 (1993). https:\/\/doi.org\/10.1016\/0046-8177(93)90088-x","journal-title":"Hum. Pathol."},{"issue":"1","key":"2544_CR62","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1210\/jc.2012-2851","volume":"98","author":"V Chortis","year":"2013","unstructured":"V. Chortis, A.E. Taylor, P. Schneider, J.W. Tomlinson, B.A. Hughes, D.M. O\u2019Neil et al. Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5\u03b1-reductase, explaining the need for personalized glucocorticoid and androgen replacement. J. Clin. Endocrinol. Metab. 98(1), 161\u2013171 (2013). https:\/\/doi.org\/10.1210\/jc.2012-2851","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02544-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-020-02544-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02544-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T15:21:18Z","timestamp":1619796078000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-020-02544-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,21]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["2544"],"URL":"https:\/\/doi.org\/10.1007\/s12020-020-02544-6","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,21]]},"assertion":[{"value":"17 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}